Side Effects Evaluation of the Use of Metformin and Glimepiride Combination In Type 2 Diabetes Mellitus Outpatients

The combination of metformin and glimepiride can significantly reduce fasting blood glucose, post prandial blood glucose, and HbA1c levels. Side effects that often occur in the use of metformin are gastrointestinal disturbances. This study aims to determine the side effects of using a combination o...

Full description

Saved in:
Bibliographic Details
Main Authors: Ni Nyoman Wahyu Udayani, I Gusti Agung Ayu Kusuma Wardani, I Dewa Ayu Anom Yustari Nida
Format: Article
Language:English
Published: Universitas Mahasaraswati Denpasar 2022-09-01
Series:Jurnal Ilmiah Medicamento
Subjects:
Online Access:https://e-journal.unmas.ac.id/index.php/Medicamento/article/view/3164
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849228440306188288
author Ni Nyoman Wahyu Udayani
I Gusti Agung Ayu Kusuma Wardani
I Dewa Ayu Anom Yustari Nida
author_facet Ni Nyoman Wahyu Udayani
I Gusti Agung Ayu Kusuma Wardani
I Dewa Ayu Anom Yustari Nida
author_sort Ni Nyoman Wahyu Udayani
collection DOAJ
description The combination of metformin and glimepiride can significantly reduce fasting blood glucose, post prandial blood glucose, and HbA1c levels. Side effects that often occur in the use of metformin are gastrointestinal disturbances. This study aims to determine the side effects of using a combination of metformin and glimepiride in outpatient type 2 diabetes mellitus at a hospital in Gianyar. This research is an observational research and data collection is done with a cross sectional approach and analyzed using descriptive methods. Data was taken by looking at the patient's medical record, including name, medical record number, gender, age, drugs given, patient diagnosis, and patient complaints during therapy. Sampling used purposive sampling technique with a total of 70 patients who entered the inclusion criteria. The results show that the number of women (62.86%). The most age range suffering from type 2 diabetes mellitus is 56-65 years (52.86%). The highest percentage of people with type 2 diabetes mellitus had a basic education level (40.00%). The side effects obtained from the combination of metformin and glimepiride in patients with type 2 diabetes mellitus at the hospital were nausea and vomiting (31.43%), flatulence (25.71%), fatigue (17.14%), headache (15.72%), and hypoglycemia (10.00%).
format Article
id doaj-art-643c54f7d1ae49ebaf013b7919ee8880
institution Kabale University
issn 2356-4814
language English
publishDate 2022-09-01
publisher Universitas Mahasaraswati Denpasar
record_format Article
series Jurnal Ilmiah Medicamento
spelling doaj-art-643c54f7d1ae49ebaf013b7919ee88802025-08-23T03:22:10ZengUniversitas Mahasaraswati DenpasarJurnal Ilmiah Medicamento2356-48142022-09-0182Side Effects Evaluation of the Use of Metformin and Glimepiride Combination In Type 2 Diabetes Mellitus OutpatientsNi Nyoman Wahyu Udayani0I Gusti Agung Ayu Kusuma Wardani1I Dewa Ayu Anom Yustari Nida2Universitas Mahasaraswati DenpasarUniversitas Mahasaraswati DenpasarUniversitas Mahasaraswati Denpasar The combination of metformin and glimepiride can significantly reduce fasting blood glucose, post prandial blood glucose, and HbA1c levels. Side effects that often occur in the use of metformin are gastrointestinal disturbances. This study aims to determine the side effects of using a combination of metformin and glimepiride in outpatient type 2 diabetes mellitus at a hospital in Gianyar. This research is an observational research and data collection is done with a cross sectional approach and analyzed using descriptive methods. Data was taken by looking at the patient's medical record, including name, medical record number, gender, age, drugs given, patient diagnosis, and patient complaints during therapy. Sampling used purposive sampling technique with a total of 70 patients who entered the inclusion criteria. The results show that the number of women (62.86%). The most age range suffering from type 2 diabetes mellitus is 56-65 years (52.86%). The highest percentage of people with type 2 diabetes mellitus had a basic education level (40.00%). The side effects obtained from the combination of metformin and glimepiride in patients with type 2 diabetes mellitus at the hospital were nausea and vomiting (31.43%), flatulence (25.71%), fatigue (17.14%), headache (15.72%), and hypoglycemia (10.00%). https://e-journal.unmas.ac.id/index.php/Medicamento/article/view/3164glimepiridemetforminside effect of drugstype 2 diabetes mellitus
spellingShingle Ni Nyoman Wahyu Udayani
I Gusti Agung Ayu Kusuma Wardani
I Dewa Ayu Anom Yustari Nida
Side Effects Evaluation of the Use of Metformin and Glimepiride Combination In Type 2 Diabetes Mellitus Outpatients
Jurnal Ilmiah Medicamento
glimepiride
metformin
side effect of drugs
type 2 diabetes mellitus
title Side Effects Evaluation of the Use of Metformin and Glimepiride Combination In Type 2 Diabetes Mellitus Outpatients
title_full Side Effects Evaluation of the Use of Metformin and Glimepiride Combination In Type 2 Diabetes Mellitus Outpatients
title_fullStr Side Effects Evaluation of the Use of Metformin and Glimepiride Combination In Type 2 Diabetes Mellitus Outpatients
title_full_unstemmed Side Effects Evaluation of the Use of Metformin and Glimepiride Combination In Type 2 Diabetes Mellitus Outpatients
title_short Side Effects Evaluation of the Use of Metformin and Glimepiride Combination In Type 2 Diabetes Mellitus Outpatients
title_sort side effects evaluation of the use of metformin and glimepiride combination in type 2 diabetes mellitus outpatients
topic glimepiride
metformin
side effect of drugs
type 2 diabetes mellitus
url https://e-journal.unmas.ac.id/index.php/Medicamento/article/view/3164
work_keys_str_mv AT ninyomanwahyuudayani sideeffectsevaluationoftheuseofmetforminandglimepiridecombinationintype2diabetesmellitusoutpatients
AT igustiagungayukusumawardani sideeffectsevaluationoftheuseofmetforminandglimepiridecombinationintype2diabetesmellitusoutpatients
AT idewaayuanomyustarinida sideeffectsevaluationoftheuseofmetforminandglimepiridecombinationintype2diabetesmellitusoutpatients